Pioneering diagnostics, treatments and vaccines

We are working on better diagnostic strategies, therapeutics and vaccines, for ma‌jor human and animal health problems. This includes tackling drug resistance in viruses, bacteria and parasites.

Highlights of our research include:

Pneumococcal vaccine

We are studying the persistence of vaccine type Streptococcus ‌‌pneumonia in Malawi following the introduction of the vaccine. Read more...


The gut microbiome

We are investigating the impact of maternally derived antibodies and infant ‌microbiota on the effectiveness of ‌rotavirus vaccines. Read more...


‌Developing new drug combinations for multi-drug resistant tuberculosis

We are leading PreDiCT-TB, a €25 million partnership aiming to develop a new, shorter treatment regimen for TB patients. Read more...


NIHR Health Protection Research Unit in Gastrointestinal Infections

A centre of excellence in multidisciplinary research aiming to find new strategies to reduce diarrhoeal disease burden and associated health inequalities. Read more...


Liverpool-Malawi Vaccine Initiative (LMVI)

We are undertaking basic and applied research to inform the development and implementation of vaccines against leading infectious diseases and train the next generation of vaccine scientists. Read more...


Women’s Improvement of Sexual and reproductive Health (‌WISH)

We are conducting research to examine the feasability of point-of-care diagnostic tests for women in Rwanda. Read more here...


Latest news

Rotavirus vaccine reduces severe diarrhoea by 64% in ‌Malawi

Research led by Professor Nigel Cunliffe has found that diarrhoea caused by rotavirus infection is significantly reduced in the developing world with the use of a vaccine to prevent the condition. Read more...

Could liposomes be the answer to our antibiotic crisis?

New research led by Professor Aras Kadioglu, and published in Nature Biotechnology, has demonstrated a new treatment against antibiotic resistant bacterial infections. Read more...

New approaches for Ebola virus therapeutics

In collaboration with Public Health England, a team led by Professor Julian Hiscox has investigated new ways to identify drugs that could be used to treat Ebola virus infection. Read more...